[Incidence, prevention and therapy of cytomegalovirus and pneumocystis carinii pneumonia after liver transplantation].
Lauchart
W
W
Abteilung Allgemeinchirurgie, Eberhard-Karls-Universität, Tübingen.
D000212:Acyclovir / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000276:immunology; D017245:Foscarnet / Q000008:administration & dosage; D015774:Ganciclovir / Q000008:administration & dosage; D006801:Humans; D007116:Immunization, Passive; D016031:Liver Transplantation / Q000276:immunology*; D009894:Opportunistic Infections / Q000188:drug therapy* / Q000276:immunology; D010419:Pentamidine / Q000008:administration & dosage; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy* / Q000276:immunology; D011024:Pneumonia, Viral / Q000188:drug therapy* / Q000276:immunology; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage
D017245:Foscarnet; D010419:Pentamidine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D015774:Ganciclovir; D000212:Acyclovir
Inzidenz, Prophylaxe und Therapie der Zytomegalovirus-(CMV-) und Pneumocystis-carinii-Pneumonie nach Lebertransplantation.